Orbicular Pharmaceutical Technologies Private Limi — Liraglutide Exporter Profile
Indian Pharmaceutical Exporter · #2 for Liraglutide · $1.9M export value · DGFT Verified
Orbicular Pharmaceutical Technologies Private Limi is the #2 Indian exporter of Liraglutide with $1.9M in export value and 91 verified shipments. Orbicular Pharmaceutical Technologies Private Limi holds a 43.9% market share in Liraglutide exports across 9 countries.
Orbicular Pharmaceutical Technologies Private Limi — Liraglutide Export Profile: Buyers & Destinations
Where Does Orbicular Pharmaceutical Technologies Private Limi Export Liraglutide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SOUTH AFRICA | $150.0K | 3 | 48.3% |
| HONG KONG | $100.0K | 2 | 32.2% |
| SAUDI ARABIA | $50.0K | 1 | 16.1% |
| BRAZIL | $10.0K | 6 | 3.2% |
| UNITED STATES | $490 | 36 | 0.2% |
| GERMANY | $53 | 26 | 0.0% |
| UNITED KINGDOM | $37 | 2 | 0.0% |
| POLAND | $13 | 8 | 0.0% |
| CANADA | $2 | 10 | 0.0% |
Orbicular Pharmaceutical Technologies Private Limi exports Liraglutide to 9 countries. The largest destination is SOUTH AFRICA accounting for 48.3% of Orbicular Pharmaceutical Technologies Private Limi's Liraglutide shipments, followed by HONG KONG (32.2%) and SAUDI ARABIA (16.1%). These destinations reflect Orbicular Pharmaceutical Technologies Private Limi's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Liraglutide from Orbicular Pharmaceutical Technologies Private Limi?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| M/S MEDPRO PHARMACEUTICA PTY LTD | SOUTH AFRICA | $150.0K | 3 |
| SUCCEED HOLDINGS LTD. | HONG KONG | $100.0K | 2 |
| M/S BOSTON ONCOLOGY ARABIA | SAUDI ARABIA | $50.0K | 1 |
| CIPLA BRASIL IMPORTADORA E DISTRIBU | BRAZIL | $5.0K | 2 |
| CIPLA BRASIL IMPORTADORA E | BRAZIL | $4.8K | 3 |
| M/S.HTL BIOSOLUTIONS INC. | UNITED STATES | $271 | 13 |
| CIPLA BRASIL IMPORTADORA E DISTRIBULDORA DE MEDICAMENTOS LIMITED | BRAZIL | $131 | 1 |
| M S HTL BIO SOLUTIONS INC | UNITED STATES | $60 | 8 |
| M/S. 3B PHARMACEUTICALS GMBH | GERMANY | $49 | 2 |
| M/S.LONZA BIOLOGICS | UNITED STATES | $48 | 4 |
Orbicular Pharmaceutical Technologies Private Limi supplies Liraglutide to 26 buyers globally. The largest buyer is M/S MEDPRO PHARMACEUTICA PTY LTD (SOUTH AFRICA), followed by SUCCEED HOLDINGS LTD. (HONG KONG) and M/S BOSTON ONCOLOGY ARABIA (SAUDI ARABIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Liraglutide Export Value and How Much Does Orbicular Pharmaceutical Technologies Private Limi Contribute?
India exported $2.7M worth of Liraglutide through 416 shipments from 53 suppliers to 36 countries, serving 121 buyers globally. Orbicular Pharmaceutical Technologies Private Limi contributes $1.9M to this total, accounting for 43.9% of India's Liraglutide exports. Orbicular Pharmaceutical Technologies Private Limi ships Liraglutide to 9 countries through 26 buyers.
What Is the Average Shipment Value for Orbicular Pharmaceutical Technologies Private Limi's Liraglutide Exports?
Orbicular Pharmaceutical Technologies Private Limi's average Liraglutide shipment value is $20.6K per consignment, based on 91 shipments totaling $1.9M. The largest destination is SOUTH AFRICA (48.3% of Orbicular Pharmaceutical Technologies Private Limi's Liraglutide exports).
How Does Orbicular Pharmaceutical Technologies Private Limi Compare to Other Indian Liraglutide Exporters?
Orbicular Pharmaceutical Technologies Private Limi ranks #2 among 53 Indian Liraglutide exporters with a 43.9% market share. The top 3 exporters are ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI ($1.9M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($750.0K), LUPIN LIMITED ($35.4K). Orbicular Pharmaceutical Technologies Private Limi processed 91 shipments to 9 destination countries.
What Liraglutide Formulations Does Orbicular Pharmaceutical Technologies Private Limi Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LIRAGLUTIDE INJECTION 18mg/3mL(6mg/mL)(EACH 3ML CONTAINS LIRAGLUTIDE 18MG)FILL VOLUME 3.3ML(3000 Boxes 3Nos per Box=9000 | $50.0K | 1 |
| LIRAGLUTIDE INJECTION 18mg/3mL(6mg/mL)(EACH 3ML CONTAINS LIRAGLUTIDE 18MG)FILL VOLUME 3.3ML(3630 PACKS 3Nos per Box=10,8 | $50.0K | 1 |
| ZELYSSA(LIRAGLUTIDE INJECTION,IH,18mg/3mL(6mg/mL)0.6mg,1.2mg or 1.8mg,2.4mg or 3.0mg per Dose)(1848 Packs at 5 Nos per B | $50.0K | 1 |
| GILIPTRA 6MG/ML 2X 3ML PREFILLED PEN (LIRAGLUTIDE INJECTION 18 MG/3 ML (6 MG/ML)((TOTAL QTY PACKS 18009X2=36018 NOS) | $50.0K | 1 |
| GILIPTRA 6MG/ML 3X 3ML PREFILLED PEN (LIRAGLUTIDE INJECTION 18 MG/3 ML (6 MG/ML)(30306 NOS) | $50.0K | 1 |
| GILIPTRA 6MG/ML 3X 3ML PREFILLED PEN (LIRAGLUTIDE INJECTION 18 MG/3 ML (6 MG/ML)(7314 NOS) | $50.0K | 1 |
| LIRAGLUTIDE INJECTION 18MG/3ML(6MG/ML), | $3.8K | 1 |
| LIRAGLUTIDE INJECTION 6MG/ML | $3.2K | 4 |
| PLACEBO FOR LIRAGLUTIDE INJECTION 18MG/3ML(6MG/ML), | $1.3K | 1 |
| PLACEBO FOR LIRAGLUTIDE INJECTION 6MG /ML | $904 | 1 |
Orbicular Pharmaceutical Technologies Private Limi exports 48 distinct Liraglutide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LIRAGLUTIDE INJECTION 18mg/3mL(6mg/mL)(EACH 3ML CONTAINS LIR with 1 shipments worth $50.0K.
Regulatory Requirements: Exporting Liraglutide to Key Markets
What Orbicular Pharmaceutical Technologies Private Limi must comply with to export Liraglutide to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Orbicular Pharmaceutical Technologies Private Limi Compare to Nearest Liraglutide Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI ★ | $1.9M | 91 | 9 | $20.6K |
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $750.0K | 15 | 4 | $50.0K |
| 3 | LUPIN LIMITED | $35.4K | 10 | 3 | $3.5K |
Orbicular Pharmaceutical Technologies Private Limi ranks #2 among 53 Indian Liraglutide exporters. Average shipment value of $20.6K compared to the market average of $51.4K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and LUPIN LIMITED.
Which Indian Ports Ship Liraglutide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 85 | 20.4% |
| HYDERABAD ACC (INHYD4) | 76 | 18.3% |
| HYDERABAD AIR | 66 | 15.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 31 | 7.5% |
| HAZIRA PORT SURAT ICD | 31 | 7.5% |
| AHEMDABAD AIR | 18 | 4.3% |
| BANGALORE AIR | 18 | 4.3% |
| Hyderabad Air | 9 | 2.2% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Liraglutide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Liraglutide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Orbicular Pharmaceutical Technologies Private Limi matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 94 individual customs records matching Orbicular Pharmaceutical Technologies Private Limi exporting Liraglutide, covering 48 formulations to 9 countries via 26 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 36+ countries, 121+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Liraglutide Export Data from Orbicular Pharmaceutical Technologies Private Limi
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Orbicular Pharmaceutical Technologies Private Limi's Liraglutide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Orbicular Pharmaceutical Technologies Private Limi
Company Profile
0 products · $0 total trade · 0 categories
Liraglutide Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Orbicular Pharmaceutical Technologies Private Limi.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Liraglutide. For current shipment-level data, contact TransData Nexus.